Author

Yi-Cheng Jim Wang

Observed name: Yi-Cheng Wang

Institution: Children's Oncology Group

Observed institution: Children's Oncology Group

ORCID: 0009-0005-7623-7789

Observed ORCID: 0009-0005-7623-7789

OpenAlex ID: A5048572556

Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML) Have Increased Treatment-Related Mortality with Similar Outcomes -- a Report from the Children's Oncology Group Trials AAML03P1 and AAML0531

2014 · Keith J. August, Richard Aplenc, et al. · Blood · 9

Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia

2025 · Richard J. Marrero, Vivek M. Shastri, et al. · JAMA Network Open · 4

DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children’s Oncology Group

2024 · Vivek M. Shastri, Lata Chauhan, et al. · Clinical Cancer Research · 2

Supplementary Tables 1 from DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children’s Oncology Group

2025 · Vivek M. Shastri, Lata Chauhan, et al.

Supplementary Figures 1 from DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children’s Oncology Group

2025 · Vivek M. Shastri, Lata Chauhan, et al.

Data from DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children’s Oncology Group

2025 · Vivek M. Shastri, Lata Chauhan, et al.

Supplementary Table 5 from DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children’s Oncology Group

2025 · Vivek M. Shastri, Lata Chauhan, et al.

Gemtuzumab ozogamycin (GO) and toxic mortality (TM) in children and adolescents with acute myeloid leukemia (AML) enrolled on Children’s Oncology Group (COG) trial AAML0531.

2015 · Jaszianne A. Tolbert, Lillian Sung, et al. · Journal of Clinical Oncology

Works count: 8

Citation count: 15

H-index: 2

I10-index: